{"id":904164,"date":"2025-11-03T09:55:56","date_gmt":"2025-11-03T14:55:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/"},"modified":"2025-11-03T09:55:56","modified_gmt":"2025-11-03T14:55:56","slug":"compass-therapeutics-to-participate-in-upcoming-november-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/","title":{"rendered":"Compass Therapeutics to Participate in Upcoming November Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (\u201cCompass\u201d) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November.<\/p>\n<p>\n        <strong>Details are as follows: <\/strong>\n      <\/p>\n<p>\n        <strong>Guggenheim 2nd Annual Healthcare Innovation Conference<\/strong><br \/>\n        <br \/>\n        <strong>Location:<\/strong> Boston, MA<br \/><strong>Date:<\/strong> Monday, November 10, 2025 <br \/><strong>Time:<\/strong> 3:30 PM ET<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_RaoNHcJoJ6zCNttbsgG5CnLJtTNUxty4YYf6Xg-P9CoiffZJ0bqImaP9LZV5zockEbBcxRufDtxk4XQ1PSPv3Lt_Jovr6VjWs_L3_rvy4-1CKEXQIFFky1Hr18FT1DKkaxFXdaaLT9a3ltawUVsPWcgEfpSUzvigickpZ7vRl_4lEercE1EpQohNGJuLQ2J9qumJKtvgJjPlhmD0aELec1esx-QOAz2L-mwds041uC9UJhawCwEy8c9q5G9fUMY\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.summitcast.com\/view\/6h3HS7z68WnTQE5PS7Vq8J\/Whrfp7V7J4xxPSb6WEtmkp<\/a><\/p>\n<p>\n        <strong>Stifel 2025 Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Location:<\/strong> New York, NY<br \/><strong>Date:<\/strong> Wednesday, November 12, 2025<br \/><strong>Time:<\/strong> 4:00 PM ET <br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_RaoNHcJoJ6zCNttbsgG5CnLJtTNUxty4YYf6Xg-P9Bmuh3pfuCt0d89y15yvbk6wF6v7cQ3ExUd-3SYcAUihHaUI-U0nvWn8YK6dOnQDGZQZT7E_6YhThoGltn9omQ5JYW8sInz1uffGncnktizBsoJ9kZL-B-1iN40DYVXv6c2ka6YVtssEvC7zupQcnqwMsebNWd2XjIFdi4N7LErj4c_IL3tuq0oz0ouFtrBaSMLarcHpP07OBSF3drQMd6U\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.summitcast.com\/view\/cwkmPXkC4dosg6MoG95rxb\/PK2LUcfo5tANjQo7JVHDsB<\/a><\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Location:<\/strong> London, UK<br \/><strong>Date:<\/strong> Thursday, November 20, 2025 <br \/><strong>Time:<\/strong> 12:00 PM GMT<br \/><strong>Webcast Link:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_RaoNHcJoJ6zCNttbsgG5PlcC1VdVmLTbk8hazZGwyQ1oEHb9WpFtaE20QdHu_7ZaKZihfqHXB6RyZp7yFL4E6HvgCFlEdP7mDyDyKmvLM_3M_MKR7wC0FEvPKTuCrd83RdqZtTCQQKiCtbsT6UzeMdxyrjr7DVcGg9ATeaR8admvYnFkW8ovyXhlSK36YBgt9dFOvENP9qOfLOqmyP74w==\" rel=\"nofollow\" target=\"_blank\">https:\/\/wsw.com\/webcast\/jeff332\/cmpx\/1860808<\/a><\/p>\n<p>\n        <strong>Virtual\/Replay availability:\u00a0<\/strong>Presentations will be archived for 90 days on Compass\u2019\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=14y8S-CIimhTx-aA0lPlJsy6wQNq_jLTFcXvzfYLdg_PWH-quLMVIvaqYRx-3Wl7Jci1Bn5RPvROdbB7vvFgJbg1V5zcYiUVLicjvOOA2NMhHsw1GcYU4O2mJH8Ib-8IJiWZFLZgILQOp8iuWuhF9MWtJ93Dpu1afLFoAaU1XUHqldBOsdmvm67pyeyHfW1SbygdDzIc1sXEI7Omrna2PhplCDxlcRLZGidIKlJC50xdcJFV2wshIxgM7kfpdK892nOfsu5RrcgYVMr7yeUGDQK5k_LKw5MEcdbroFgWJouZ_-2_w3BPhwqIrPGPAQyLANlMLN8A2038gdT6iId1_yio9E0rwGMTpQIV2n36bhmGUfd319FVvS7CRGtZYleI3Ge7VhEeKIOW6Bvwtn9VuulAr9cci2t_4G-9X1_BisL0ZFOiAPdO30TzRQ-D_9pth7RkQGravLf6biIBBwSyxngqx7riM-I7kaHMeo4_ZYM=\" rel=\"nofollow\" target=\"_blank\"><strong>Events<\/strong><\/a>\u00a0page.<\/p>\n<p>\n        <strong>About Compass Therapeutics<\/strong><br \/>\n        <br \/>Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x130aNfeye7NUoSO2ni-F7eXrrpJjKdlbUqFZbV5Je4lDCUG3ZrwAqDRH7B1mIQ2kPIe1SBHG2Lj9oEWTqC5_jHjHepFhFuzk97xMDIN-21E9W4HPqjswszlD0MmQuxW\" rel=\"nofollow\" target=\"_blank\">ir@compasstherapeutics.com<\/a>\u00a0<\/strong>\n      <\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Anna Gifford, Chief of Staff<br \/><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5--Ps70RZwxamaCKWAJZuX3YghgOBLdo0VQy9qUwk1ktUf5Zsm3Jpdl5ott3PrfyAKgCWoh0n9YBXG56uHaNJDr4TE2Ezuj18Olo8Bpm4ioytWpABV3AJ9rK8OZbc5-x\" rel=\"nofollow\" target=\"_blank\">media@compasstherapeutics.com<\/a>\u00a0<\/strong><br \/>617-500-8099<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTNhYjgzMTAtZDliOC00YmM5LWJjYjktYTFhMjdmMThiYjRkLTEyMTM5NzUtMjAyNS0xMS0wMy1lbg==\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (\u201cCompass\u201d) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November. Details are as follows: Guggenheim 2nd Annual Healthcare Innovation Conference Location: Boston, MADate: Monday, November 10, 2025 Time: 3:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/6h3HS7z68WnTQE5PS7Vq8J\/Whrfp7V7J4xxPSb6WEtmkp Stifel 2025 Healthcare Conference Location: New York, NYDate: Wednesday, November 12, 2025Time: 4:00 PM ET Webcast Link: https:\/\/event.summitcast.com\/view\/cwkmPXkC4dosg6MoG95rxb\/PK2LUcfo5tANjQo7JVHDsB Jefferies Global Healthcare Conference Location: London, UKDate: Thursday, November 20, 2025 Time: 12:00 PM GMTWebcast Link:https:\/\/wsw.com\/webcast\/jeff332\/cmpx\/1860808 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Participate in Upcoming November Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904164","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (\u201cCompass\u201d) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November. Details are as follows: Guggenheim 2nd Annual Healthcare Innovation Conference Location: Boston, MADate: Monday, November 10, 2025 Time: 3:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/6h3HS7z68WnTQE5PS7Vq8J\/Whrfp7V7J4xxPSb6WEtmkp Stifel 2025 Healthcare Conference Location: New York, NYDate: Wednesday, November 12, 2025Time: 4:00 PM ET Webcast Link: https:\/\/event.summitcast.com\/view\/cwkmPXkC4dosg6MoG95rxb\/PK2LUcfo5tANjQo7JVHDsB Jefferies Global Healthcare Conference Location: London, UKDate: Thursday, November 20, 2025 Time: 12:00 PM GMTWebcast Link:https:\/\/wsw.com\/webcast\/jeff332\/cmpx\/1860808 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage &hellip; Continue reading &quot;Compass Therapeutics to Participate in Upcoming November Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T14:55:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in Upcoming November Investor Events\",\"datePublished\":\"2025-11-03T14:55:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/\",\"name\":\"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\",\"datePublished\":\"2025-11-03T14:55:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in Upcoming November Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","og_description":"BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (\u201cCompass\u201d) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November. Details are as follows: Guggenheim 2nd Annual Healthcare Innovation Conference Location: Boston, MADate: Monday, November 10, 2025 Time: 3:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/6h3HS7z68WnTQE5PS7Vq8J\/Whrfp7V7J4xxPSb6WEtmkp Stifel 2025 Healthcare Conference Location: New York, NYDate: Wednesday, November 12, 2025Time: 4:00 PM ET Webcast Link: https:\/\/event.summitcast.com\/view\/cwkmPXkC4dosg6MoG95rxb\/PK2LUcfo5tANjQo7JVHDsB Jefferies Global Healthcare Conference Location: London, UKDate: Thursday, November 20, 2025 Time: 12:00 PM GMTWebcast Link:https:\/\/wsw.com\/webcast\/jeff332\/cmpx\/1860808 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage &hellip; Continue reading \"Compass Therapeutics to Participate in Upcoming November Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T14:55:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in Upcoming November Investor Events","datePublished":"2025-11-03T14:55:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/","name":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=","datePublished":"2025-11-03T14:55:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NTYxMSM3MjI5ODk4IzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in Upcoming November Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904164"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904164\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}